Henlius Wins CHMP Support for Serplulimab in Lung Cancer
Shanghai, China, May 23, 2026 Henlius Biotech has announced that the Committee for Medicinal Products for Human Use (CHMP)...
EMA
Advertisement
Pierre Fabre Gains CHMP Support for BRAFTOVI®
Castres, France, May 22, 2026 Pierre Fabre Laboratories has announced that the Committee for Medicinal Products for Human Use...
Novo Nordisk’s Wegovy 7.2 mg Wins CHMP Support
BAGSVÆRD, Denmark, May 22, 2026 Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Gilead’s Trodelvy Wins CHMP Support in 1L TNBC
FOSTER CITY, Calif., May 25, 2026 Gilead Sciences announced that the European Medicines Agency’s Committee for Medicinal Products for...
Boehringer Ingelheim Strengthens Fibrosis Portfolio With JASCAYD
Ingelheim, Germany – May 22, 2026 Boehringer Ingelheim announced that the European Medicines Agency’s Committee for Medicinal Products for...
Advertisements
Teva Advances Schizophrenia Therapy in Europe
TEL AVIV, Israel & PARIS, May 21, 2026 Teva Pharmaceuticals and Medincell have announced that the European Medicines Agency...
BioMarin Reports Positive Phase 3 VOXZOGO Data in Hypochondroplasia
SAN RAFAEL, Calif., May 20, 2026 BioMarin Pharmaceutical Inc. announced positive topline results from the pivotal Phase 3 CANOPY-HCH-3...
MaaT Pharma Receives Negative CHMP Trend for MaaT013 in aGvHD
Lyon, France, May 20, 2026 MaaT Pharma announced that the Committee for Medicinal Products for Human Use (CHMP) of...
AstraZeneca and Daiichi Sankyo Secure FDA Approval for Enhertu in Early HER2 Breast Cancer
WILMINGTON, Del., May 15, 2026 AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA)...
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
Advertisement
